Ambit Biosciences Corporation IPO Research Information

Ambit Biosciences Corporation IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Ambit Biosciences Corporation, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Ambit Biosciences Corporation	AMBI - NASDAQ	$8.00-$8.00	$8.00	$8.00	8.1 million	5/16/2013
Underwriter(s): Citigroup, Leerink Swann
Co-Manager(s): BMO Capital Markets, Baird
Industry: Health Care
Filing(s): Refiled 2013-02-20

Ambit Biosciences Corporation Quote & Chart - Click for current quote - AMBI

About Ambit Biosciences Corporation (adapted from Ambit Biosciences Corporation prospectus):
They are a biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases

This description is adapted from Ambit AMBT prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Ambit AMBT "AMBI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.